ResMetrix Medical News
4 articles
Israeli firm develops remote app to detect respiratory worsening of COVID-19 patients
Resmetrix Medical, an Israeli start-up company, has developed a system for accurate remote monitoring of the respiratory status of COVID-19 patients in the hospital and at home. The system uses innovative technology, including a wearable sensor and a smartphone application, to measure breath patterns and volume. It provides real-time information and alerts to the medical team, enabling early detection of respiratory aggravation. The system aims to streamline treatments by detecting breathing deterioration in mild condition patients at home and monitoring patients in moderate condition in hospitals quarantined wards. It also provides valuable clinical information for the scientific community to examine possible treatments to prevent exacerbation. The article was published on April 5, 2021.
CustomersPartners
Wearable monitor could prevent rehospitalization for COPD
Resmetrix Medical, an Israeli company, is developing a wearable health device that continuously monitors and analyzes breathing patterns to detect early signs of deterioration in patients with chronic obstructive pulmonary disease (COPD). The device, which uses a unique chest strap, can be used to manage other respiratory diseases as well. COPD affects over 250 million people globally and is a major burden on healthcare systems. Resmetrix aims to reduce rehospitalizations and associated costs by providing post-discharge monitoring for COPD patients. The company plans to conduct pilot studies in the US and Europe within a year and a half to two years, pending FDA and CE approvals.
Customers
האקזיט הבא? חברת המכשור הרפואי המבטיחה מחיפה מגייסת משקיעים
Israeli company Resmetrix has developed a unique sensor that can identify respiratory problems and changes in patterns. The sensor is attached to the patients body and can alert them via a mobile app, potentially saving lives. The company, established in 2017, has already tested the prototype on 30 patients at Rambam Hospital in Haifa, with successful results. Hospitals and pharmaceutical companies worldwide have expressed interest in the product, which could significantly reduce healthcare system costs by reducing hospitalizations and patient deterioration. The company is now allowing up to 35 Israeli investors to invest in it through the Together investment club.
InvestmentCustomers
Israeli chest strap keeps tabs on pulmonary patients' breathing
Israeli company Resmetrix Medical has developed a device that allows respiratory patients to monitor their condition at home, detecting early signs of exacerbation and preventing costly hospitalizations. The device is a chest strap that connects wirelessly to a smartphone application with cloud-based analysis. It tracks respiratory patterns, heart rate, and body temperature, comparing the measurements to the patients baseline using AI algorithms. The device provides interactive feedback to the patient about their respiratory status, with green indicating normal, orange indicating deterioration, and red indicating severity. Resmetrix Medical is conducting a clinical study and plans to request regulatory approvals in about two years. The company has raised $750,000 and is seeking additional funding.
CustomersInvestment
